JPH0215521B2 - - Google Patents

Info

Publication number
JPH0215521B2
JPH0215521B2 JP55067375A JP6737580A JPH0215521B2 JP H0215521 B2 JPH0215521 B2 JP H0215521B2 JP 55067375 A JP55067375 A JP 55067375A JP 6737580 A JP6737580 A JP 6737580A JP H0215521 B2 JPH0215521 B2 JP H0215521B2
Authority
JP
Japan
Prior art keywords
cimetidine
formulation
present
fine granules
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55067375A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56164122A (en
Inventor
Dotaro Fujimoto
Masafumi Hase
Yoshihiro Shimizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujimoto Pharmaceutical Corp
Original Assignee
Fujimoto Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Pharmaceutical Corp filed Critical Fujimoto Pharmaceutical Corp
Priority to JP6737580A priority Critical patent/JPS56164122A/ja
Publication of JPS56164122A publication Critical patent/JPS56164122A/ja
Publication of JPH0215521B2 publication Critical patent/JPH0215521B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6737580A 1980-05-21 1980-05-21 Drug composition comprising cimetidine as main agent Granted JPS56164122A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6737580A JPS56164122A (en) 1980-05-21 1980-05-21 Drug composition comprising cimetidine as main agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6737580A JPS56164122A (en) 1980-05-21 1980-05-21 Drug composition comprising cimetidine as main agent

Publications (2)

Publication Number Publication Date
JPS56164122A JPS56164122A (en) 1981-12-17
JPH0215521B2 true JPH0215521B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-04-12

Family

ID=13343195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6737580A Granted JPS56164122A (en) 1980-05-21 1980-05-21 Drug composition comprising cimetidine as main agent

Country Status (1)

Country Link
JP (1) JPS56164122A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
YU120988A (en) * 1988-06-23 1990-06-30 Lek Tovarna Farmacevtskih Process for preparing new dispersion pills of cimetidine
AU4803490A (en) * 1988-12-22 1990-07-10 Hubner Gummi-Und Kunststoff Gmbh Multi-section vehicle, in particular an articulated bus
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions
KR20060126688A (ko) 2003-12-09 2006-12-08 다이닛본 스미토모 세이야꾸 가부시끼가이샤 약물-함유 입자 및 그 입자를 함유하는 고형 제제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ184893A (en) * 1976-09-21 1980-11-28 Smith Kline French Lab Pure crystalline form of cimetidine a(n-methyl-n-cyano-n-(-2-(5-methyl-4imidazolyl) methylthio) ethyl)-guanidine andpharmaceutical compositions containing it
JPS5513239A (en) * 1978-07-14 1980-01-30 Fujisawa Pharmaceut Co Ltd Fine particulate drug composition

Also Published As

Publication number Publication date
JPS56164122A (en) 1981-12-17

Similar Documents

Publication Publication Date Title
EP0293885B1 (en) Antibiotic-polymer compositions
US20030083354A1 (en) Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
EA006383B1 (ru) Фармацевтическая композиция, имеющая сниженную тенденцию кристаллизации лекарственного ингредиента
IE57158B1 (en) Liquid formulations of nimodipine,and a process for their preparation
JPH0548206B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH02111719A (ja) 薬物吸着質
JPH0587492B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO2009129592A1 (en) Liquid formulation for deferiprone with palatable taste
TW202216117A (zh) 經口用醫藥組成物及其製造方法
CN115837012A (zh) 一种氨氯地平干混悬剂及其制备方法
JPH0215521B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD238920A5 (de) Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung
EP0310999B1 (en) Pharmaceutical composition for piperidinoalkanol derivatives
JP2020132613A (ja) ラメルテオン含有固形製剤
US20040132827A1 (en) Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
KR100479367B1 (ko) 이트라코나졸을 포함하는 경구투여용 항진균제 조성물
KR101019769B1 (ko) 경구 흡수성이 개선된 항균성 약제학적 조성물
US4241047A (en) Novel medicinal composition for the treatment of biliary lithiasis
JPS5824514A (ja) 消化性潰瘍治療剤
EP3854384A1 (en) Pharmaceutical formulation comprising abiraterone acetate
JPH0737383B2 (ja) 胃酸分泌抑制剤含有固型製剤
EP1818050A1 (de) Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor
JPS6019893B2 (ja) 抗潰瘍剤
EP0140492B1 (en) L-arginine isoxicamate
JPS6213326B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)